Biodegradable nanoparticles containing TLR3 or TLR9 agonists together with antigen enhance MHC-restricted presentation of the antigen

Arch Pharm Res. 2010 Nov;33(11):1859-66. doi: 10.1007/s12272-010-1119-z. Epub 2010 Nov 30.

Abstract

The effects of intraphagosomal toll-like receptor (TLR) activation on the MHC-restricted presentation of exogenous antigen were examined in dendritic cells (DCs). For phagosomal targeting, nanoparticles containing both a TLR agonist and a model antigen, ovalbumin (OVA), were prepared using biodegradable polymer poly(D,L-lactic acid-co-glycolic acid) and were then opsonized with mouse IgG. After incubating mouse DCs with the nanoparticles, the efficacy of OVA peptide presentation was evaluated using OVA-specific CD8 and CD4 T cells. Inclusion of either the TLR3 agonist poly(I:C) or the TLR9 agonist CpG oligodeoxynucleotides (ODN) significantly increased and prolonged both MHC class I- and class II-restricted OVA presentation. Accordingly, the DCs that phagocytosed the nanoparticles containing poly(I:C) or CpG ODN together with OVA efficiently induced the proliferation of OVA-specific CD8 and CD4 T cells. The potency levels of poly(I:C) and CpG ODN in increasing the MHC-restricted presentation of the exogenous antigen appeared to be similar. A combination of the 2 TLR agonists was synergistic in increasing the MHC class I-restricted, but not the class II-restricted, presentation of exogenous antigen. These results show that IgG-opsonized biodegradable nanoparticles containing both intraphagosomal TLR agonists and antigens can be efficient carrier materials in inducing antigen-specific T cell responses.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antigen Presentation*
  • Antigens / immunology
  • Cell Proliferation / drug effects
  • Dendritic Cells / drug effects
  • Dendritic Cells / immunology*
  • Histocompatibility Antigens Class I / immunology*
  • Immunoglobulin G / immunology
  • Lactic Acid
  • Mice
  • Nanoparticles*
  • Oligodeoxyribonucleotides / pharmacology*
  • Ovalbumin / immunology
  • Poly I-C / pharmacology*
  • Polyglycolic Acid
  • Polylactic Acid-Polyglycolic Acid Copolymer
  • T-Lymphocytes / drug effects
  • T-Lymphocytes / immunology*
  • Toll-Like Receptor 3 / agonists*
  • Toll-Like Receptor 3 / metabolism
  • Toll-Like Receptor 9 / agonists*
  • Toll-Like Receptor 9 / metabolism

Substances

  • Antigens
  • CPG-oligonucleotide
  • Histocompatibility Antigens Class I
  • Immunoglobulin G
  • Oligodeoxyribonucleotides
  • Toll-Like Receptor 3
  • Toll-Like Receptor 9
  • Polylactic Acid-Polyglycolic Acid Copolymer
  • Polyglycolic Acid
  • Lactic Acid
  • Ovalbumin
  • Poly I-C